EGFR INHIBITORS

The present disclosure provides a compound represented by structural formula (A) or (I): or a pharmaceutically acceptable salt thereof useful for treating a cancer. La présente invention concerne un composé représenté par la formule structurale (A) ou (I), ou un sel pharmaceutiquement acceptable de...

Full description

Saved in:
Bibliographic Details
Main Authors RIBEIRO DA SILVA, Vinicius, AHMAD, Omar, BARVIAN, Kevin, DINEEN, Thomas, PEROLA, Emanuele, PERRON, Quentin, FERNANDO, Dilinie, ENO, Meredith, CAMPBELL, John
Format Patent
LanguageEnglish
French
Published 12.10.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure provides a compound represented by structural formula (A) or (I): or a pharmaceutically acceptable salt thereof useful for treating a cancer. La présente invention concerne un composé représenté par la formule structurale (A) ou (I), ou un sel pharmaceutiquement acceptable de celui-ci, utile pour traiter un cancer.
Bibliography:Application Number: WO2023US17384